Zhen Fang
6PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 15, 2025
Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.Huiping Shuai, Jingxin Qiao, Chaemin Yoon
|Jul 16, 2025
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.Huiping Shuai, Jingxin Qiao, Chaemin Yoon
|Nov 28, 2024
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.Hin Chu, Huiping Shuai, Jingxin Qiao
|Jun 14, 2023
Discovery of [1,2,3]Triazolo[4,5-c]quinoline Derivatives as a New Class of Ataxia-Telangiectasia Mutated Kinase Inhibitors.Shiyu Zhang, Pei Zhou, Jingming Liu
|Mar 17, 2023
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants.Chong Huang, Huiping Shuai, Jingxin Qiao
|Oct 23, 2019
Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer.Heng Zheng, Yan Tie, Zhen Fang
Pageof 1
Frequent Collaborators
4 joint publications
Jian Lei
4 joint publications
Hin Chu
3 joint publications
Huiping Shuai
3 joint publications
Bingjie Hu
3 joint publications
Jie Zhou
3 joint publications
Jasper Fuk-Woo Chan
3 joint publications
Kwok-Yung Yuen
3 joint publications
Chunfu Xu
3 joint publications
Shengyong Yang
2 joint publications
Anjie Xia
